Skip to main content
Caplight Logo









Cellweaverse

Cellweaverse

Private
PohangHealthcare & Life Scienceshttps://cellweaverse.com

Last Round

Grant

Mar 27, 2026

Total Funding Raised

$790,000

Company Overview

Cellweaverse is a biotechnology company that develops and produces animal-derived materials without using animals through its cell culture technology for the pharmaceutical, medical, food, and cosmetic industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Compliance

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Infrastructure

Keywords

cell cultureendotoxin testingbiomaterialslab-grown materialslimulus amoebocyte lysateLALcellular microenvironmentbiotech R&Dsynthetic biologyanimal-free testingheparin alternativebioprocessingAI-driven bioprocessingclean meat tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellweaverse Comparables

Compare Cellweaverse with similar companies based on industry and business-model similarity.

Cellweaverse comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Huzhou Shenke Biotechnology Co., Ltd.
76%
SEIKAGAKU CORPORATION
74%
Charles River Laboratories
73%

Cellweaverse Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 27, 2026
SeedNov 22, 2024
GrantNov 1, 2024

Cellweaverse Investors

Notable investors and investment history

Cellweaverse investors
InvestorRounds
POSTECH Holdings Co., Ltd.Seed
Government of South KoreaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 22, 2024

    POSTECH Holdings Co., Ltd. participated in the Seed round.

  • Nov 1, 2024

    $360K awarded by the Government of South Korea.

Cellweaverse Filings

Explore SEC and related filing metadata, where available.

Cellweaverse filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cellweaverse's valuation, stock price, and market status.

Is Cellweaverse a public or private company?

Cellweaverse is a private company.

What is the current stock price of Cellweaverse?

Cellweaverse is a private company with no public stock price. Caplight tracks Cellweaverse's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Cellweaverse worth (valuation)?

Valuation information for Cellweaverse is not publicly available.

Can I buy Cellweaverse stock?

Cellweaverse shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cellweaverse's last funding round?

Cellweaverse's most recent funding round was Grant on March 27, 2026.

Who are the main investors in Cellweaverse?

Key investors in Cellweaverse include POSTECH Holdings Co., Ltd., Government of South Korea.

Will Cellweaverse IPO soon?

No public IPO plans have been announced for Cellweaverse.

How can I track Cellweaverse secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cellweaverse's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPohang
Year Founded2024
Last FundingMar 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?